As Wes Streeting takes over the UK’s Department for Health and Social care, investors wait to see if the Labour government ...
MSD (Merck & Co) plans to start a Phase IIb/III trial for EyeBio’s lead candidate, Restoret, in diabetic macular oedema in H2 ...
The cash injection will accelerate the development of Crossject’s prefilled needle free platform to treat anaphylactic shock.
Roche’s Ocrevus is currently offered on the NHS via twice-yearly intravenous (IV) infusions. Image credit: Shutterstock / ...
Pan Cancer T has announced a €4.25m ($4.62m) seed extension round to complete of preclinical studies for its leading product, ...
Decarbonisation is now the focal point of Big Pharma environmental, social and governance (ESG) strategies - can a superpill ...
The safety and effectiveness of EGCG for IBD were supported by peer-reviewed studies. Credit: MMD Creative/Shutterstock.
Boehringer Ingelheim’s For Generations framework is all in on sustainability for the long term across the ESG spectrum.
Leqembi is the first treatment proven to slow the progression of AD. Credit: Lighthunter/Shutterstock. Swedish research-based ...
According to a recent survey by biopharma solutions provider Cytiva, resilience remains a critical priority for industry ...
Parkinson’s Disease is a progressive neurodegenerative disorder. Credit: Momentum studio/Shutterstock. Bayer and Asklepios ...
FS001 incorporates a stable and cleavable linker with a potent topoisomerase I inhibitor. Credit: 15Studio/Shutterstock.